microfluidics Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx The three companies join forces to automate sample preparation for genetic testing of endocrine and GI cancers using digital microfluidics technology. Standard BioTools Q1 Revenues Fall 19 Percent In Q1 the company formerly known as Fluidigm completed a strategic evaluation process and closed a $250 million capital infusion from Casdin Capital and Viking Global Investors. Volta Labs, Miroculus Independently Harness Electrowetting for Automated NGS Sample Prep Premium The two companies vow to break the bottleneck for NGS sample prep with their automated instruments, which are based on electrowetting technology. Volta Labs Raises $20M in Series A Financing Round The Cambridge, Massachusetts-based startup plans to unveil its sequencer-agnostic, automated digital fluidics platform for sequencing sample prep in June. Droplet Genomics Debuts New Microfluidic Screening Platform, Touting Throughput, Flexibility Premium The Vilnius, Lithuania-based firm recently delivered its first instruments to customers, who are using it for a wide variety of applications. Jan 13, 2022 Florida Atlantic University Wins $1.3M NIH Grant to Develop Sample-to-Answer HIV Self-Test Dec 16, 2021 Single-Cell Startup Nodexus Raises $30M in Series A Financing Round Dec 14, 2021 Sphere Fluidics Plans New Applications for Single-Cell Isolation, Assay Platform Premium Oct 29, 2021 Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute Oct 7, 2021 Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights Premium Aug 26, 2021 Scienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab Jul 28, 2021 Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies Jun 8, 2021 Deepcell, UCLA Partner to Study AI Cell Biology Platform May 27, 2021 TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research Premium May 20, 2021 With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing Premium May 17, 2021 Namocell, SingLab Technologies Ink Distribution Agreement for Singapore May 12, 2021 Nuclera Acquires E Ink Digital Microfluidics Business May 12, 2021 Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms Premium May 11, 2021 Berkeley Lights Q1 Revenues Grow 35 Percent Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Mar 29, 2021 Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag Mar 18, 2021 Namocell, OLS OMNI Life Science Sign European Distribution Agreement Mar 3, 2021 Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy Premium Feb 25, 2021 Miroculus Raises $45M in Extended Series B Financing Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.